Navigation Links
AstraZeneca's David Brennan Elected PhRMA Board Chairman

SAN ANTONIO, April 3 /PRNewswire/ -- AstraZeneca Chief Executive Officer David Brennan was elected board chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA) today at the group's annual meeting.

In a speech to the meeting attendees, Brennan called on his industry colleagues and all segments of the health care system to work together in a new collaborative and bipartisan manner on meaningful health care reform that includes:

  • Increased access to health and prescription drug coverage for the uninsured and the under-insured.
  • Greater emphasis on disease prevention to reduce the burden of chronic diseases on individuals and the health care system as a whole.
  • Reduced co-pays for prescription medicines to bring them more in line with what patients pay for other health services.
  • Ensuring the Food and Drug Administration has the funding it needs to protect patients by effectively reviewing life-saving and enhancing medications.

Brennan said a modernized health system should also protect intellectual property and promote innovation as scientists seek cures to the world's deadliest and most debilitating illnesses.

"The pharmaceutical industry is uniquely poised to be both a source of innovative medicines and a trusted member of the health care community," Brennan said. "Pharmaceutical researchers and manufacturers can play a critical role in advancing health solutions that build on the strengths of the U.S. health care system and address its weaknesses.

"I look forward to working with my industry colleagues, policymakers, health advocacy organizations and new, nontraditional partners to promote policies that expand access to affordable health coverage, address the burden of chronic disease and close the gaps in health care quality while fostering continued innovation," Brennan said.

Brennan, who will serve as PhRMA chairman for a year, has been AstraZeneca's chief executive officer since Jan. 1, 2006. Under Brennan's leadership, AstraZeneca made a number of changes that tie directly to its mission of making a difference to patient health, including:

  • Expanding its prescription savings programs in the United States so that an uninsured family of four earning up to $60,000 per year may qualify to receive their AstraZeneca medicines for free.
  • Introducing a prescription savings program specifically for people with Medicare Part D, through which a senior couple earning up to $40,000 per year may qualify for significant savings.
  • Becoming the first company to include information about its prescription savings programs in product advertisements, and supporting FDA review of these ads.
  • Supporting disease prevention and employee wellness through sponsorship of the American Heart Association START! Program and the National Senior Games Association, and being one of the first companies to receive "CEO Cancer Gold Standard" accreditation by the CEO Roundtable on Cancer.
  • Becoming the first company to give nationwide, large-scale support to the American Cancer Society's Patient Navigator Program, which will link cancer patients at more than 50 sites across the U.S. with individuals who serve as their personal guides through various aspects of their cancer experience.
  • Supporting the National Alliance on Mental Illness's Connection Recover Support Group, which plans to provide a support group within reasonable traveling distance for every American who lives with mental illness, every day of the week, in English or Spanish, by the year 2010.
  • Becoming a founding member of the Alliance for a Stronger FDA, a coalition of organizations and individuals who support increased Congressional funding for FDA.

From 2001 until his appointment to global CEO, Brennan was president and chief executive officer of AstraZeneca LP, the Company's North America subsidiary. He was appointed Executive Board Director of AstraZeneca in 2005, with responsibility for the United States, the company's largest market, as well as all North American operations.

David began his career in 1975 at Merck, where he rose from sales representative in the U.S. division to general manager of Chibret International, a French subsidiary of Merck specializing in ophthalmics. He joined AstraMerck in 1992 with responsibility for helping to build the joint venture into a multi-billion dollar business in the United States.

Prior to the AstraZeneca merger he was responsible for business planning and development at Astra Pharmaceuticals. He was appointed senior vice president of commercial operations of AstraZeneca Pharmaceuticals LP in 1999. Brennan is an alumnus of Gettysburg College.

PhRMA represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier and more productive lives.

About AstraZeneca

AstraZeneca is engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and in the supply of healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with global healthcare sales of $ 31.6 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines. In the United States, AstraZeneca is a $13.5 billion dollar healthcare business.

For more information about AstraZeneca in the US or our AZ&Me(TM) Prescription Savings programs, please visit:

SOURCE AstraZeneca
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Dr. Norman E. Rosenthal Joins Paul McCartney and David Lynch at Press Conference for Benefit Concert
2. eHealth Initiative Applauds Appointment of David Blumenthal as New National Coordinator for Health Information Technology
3. Dr. Barry Friedberg comments on David vs. Goliath: Whos Really in the Pursuit of Patient Safety & Satisfaction?
4. Media Advisory: Medco CEO David B. Snow Jr. To Address American Enterprise Institute: Health IT: Empowering Precision Medicine
5. David Teuscher, MD, Elected Secretary of Academy Board of Councilors
6. Veteran Rehab Specialist, David Glancy, Joins Fast-Growing Alliance Seating & Mobility in Michigan
7. Paul McCartney to Headline Benefit Concert for David Lynch Foundation at Radio City Music Hall on Saturday, April 4
8. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center First in Nation to Use NaviStar(R) RMT ThermoCool(R) Catheter Since Technology Received FDA Approval
9. David W. Polly Jr., MD, Elected Secretary of Academy Board of Specialty Societies
10. The Chopra Center Introduces Mind-body Health Programs for Spanish Speakers: Chopra en Espanol Connects Spanish Speakers Worldwide to Deepak Chopra and David Simons Global Message of Wellness
11. World-Renowned Golf Instructor David Leadbetter Promotes VaNu
Post Your Comments:
(Date:10/10/2015)... ... 2015 , ... Story Chaser is a one-of-a-kind app that makes ... and inspiring stories and as words drop down and users tap the corresponding word. ... and can be interacted with, making it a more engaging game. Users can use ...
(Date:10/9/2015)... ... ... Doctors on Liens has teamed up with a renowned medical practice, ... to personal injury victims. When personal injury victims suffer major, complex injuries, they ... of conditions ailing them. With the addition of this new group of doctors ...
(Date:10/9/2015)... ... ... A new health tool that helps identify if a sore throat is ... – just in time for the cold and flu season, which the Center for ... the U.S., the real start of cold/flu season is the start of the school ...
(Date:10/9/2015)... ... 2015 , ... Head Over Heels Athletic Arts gymnast, Madelyn Williams, will attend ... Ranch in Huntsville, Texas on October 17-21. , "It's very exciting to be ... and executive director, said. “It's a stepping stone into the U.S. elite system where ...
(Date:10/9/2015)... Orleans, LA (PRWEB) , ... October 09, 2015 ... ... with offices serving New Orleans and the surrounding communities, is initiating a combined ... and medical care for unwanted animals in southern Louisiana. , Animal Rescue ...
Breaking Medicine News(10 mins):
... from exposure to medications, chemicals and other agentsSAN DIEGO, ... taking cold medication or using certain cleaning products can ... A new Web site ( ) ... latest information about the potential risks of exposure to ...
... restore sight, experts suggest , , THURSDAY, March 5 (HealthDay ... in two forms of childhood blindness has been identified ... of the link between the retinal gene SPATA7 and ... because it pinpoints a new retinal metabolic disease pathway ...
... 100 property and casualty insurers closed 2008 with net ... while the top 100 life insurers suffered unprecedented unrealized ... 2008 Top 100 Performance Monitor revealed a 67.7 percent ... industry,s top property and casualty insurers, from $48.8 billion ...
... Americas, Europe and Asia to Realize New Executive ... Tokyo Stock Exchange), a leading medical diagnostics ... announced executive leadership changes at Sysmex Corporate and ... Effective April 1, 2009, Kazuya Obe will ...
... stroke and heart disease are potential complications of type ... Americans. Now research from Tel Aviv University has found ... a risk factor accelerating cognitive decline and dementia. ... TAU,s Sackler School of Medicine, found that people with ...
... 2009 Many doctors don,t offer emergency contraception ... during emergency department visits because of misinformation about ... by The Children,s Hospital of Philadelphia. , ... reduce unintended pregnancy, the study,s authors said. ...
Cached Medicine News:
(Date:10/8/2015)...  The National Heart, Lung and Blood Institute ... Broad Institute of MIT and Harvard to provide ... well as data to support smaller pilots in ... for Precision Medicine (TOPMed) program and serves ... which will use whole genome sequencing to drive ...
(Date:10/8/2015)... 2015 ... "Natural Language Processing Market for Health ... (Rule-Based, Statistical, & Hybrid NLP Solutions), Region ... Africa, Latin America) - Global Forecast to ... --> ) has announced the ...
(Date:10/8/2015)... Oct. 08 2015 ... "Global API Market Outlook 2020" report ... has announced the addition of the "Global ... offering. --> Research and Markets ( ... "Global API Market Outlook 2020" report ...
Breaking Medicine Technology:
... Aug. 31, 2011 BioDelivery Sciences International, Inc. (Nasdaq: ... three upcoming investor conferences.  Dr. Mark A. Sirgo, President ... where he will focus on BDSI,s product pipeline, particularly ... which data from the pivotal Phase 3 efficacy study ...
... 2011 Elbit Imaging Ltd. (NASDAQ: EMITF) ... placed an Investor Relations Presentation relating to its Sources and ... "Investor Relations - Company Presentations -Analysis of Sources and Uses." ... Imaging Ltd. operates in the following principal fields of business: ...
Cached Medicine Technology:
Symbia T6, a True Point SPECT·CT system, combines a dual-detector variable angle gamma camera with a six slice CT scanner for advanced oncology, neurology, and cardiology applications....
... ACOM.PC turns every standard PC into ... internists, and cardiologists can use their ... access to image data thanks to ... 3 format and the compatible storage ...
... Soarian Cardiovascular Enterprise is a comprehensive ... care continuum from admission to follow-up. ... image acquisition, and diagnostic tools from ... provide a single, longitudinal clinical repository ...
... accurate lesion assessment plays a ... the appropriate stent size and ... (IC3D), a highly precise three-dimensional ... now able to quickly quantify ...
Medicine Products: